Zevra Therapeutics, Inc. ZVRA Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Zevra Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s interest coverage?
- Zevra Therapeutics, Inc. (ZVRA) reported interest coverage of -0× in Q1 2026.
- How has Zevra Therapeutics, Inc.'s interest coverage changed year-over-year?
- Zevra Therapeutics, Inc.'s interest coverage increased by 99.8% year-over-year, from -8.4× to -0×.
- What is the long-term trend for Zevra Therapeutics, Inc.'s interest coverage?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s interest coverage has grown at a 43.9% compound annual growth rate (CAGR), from -1.2× to -7.2×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.